Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zeneca launches cancer diagnostic kit:

This article was originally published in Clinica

Executive Summary

Uk-based Zeneca Diagnostics has launched its first cancer diagnostic kit, Elucigene K-RAS7, in Europe. The test detects the seven most common mutations in the K-ras proto-oncogene, found in the DNA of many types of cancer cells - including bowel, pancreatic and lung cancer. Zeneca claims the test is sufficiently sensitive to spot K-ras mutations even in samples containing predominantly normal tissue. It can thus give early warning of malignancy as well as typing and monitoring of known tumours. The kit is the fourth in the Elucigene series.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT081351

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel